vcvibes

Biostar Capital

BioStar Ventures V, L.P.

Late investment period

Late investment period: first sale Dec 2021, per Form D (fund age approximates vintage)

Email info@biostarcapital.com
Vintage
2021
Fund size
$78.54M to $105.83M (Form D and SEC adviser filing)
Stages
Seed, Series A, Growth
Sectors
Medical devices, Robotics
Regions
Not stated

01 · Thesis

BioStar Capital is a venture capital firm focused on transformative medical technologies, with an emphasis on cardiovascular and orthopedic devices, robotics, and smart devices that address unmet patient needs.Inferred from the firm's website

02 · Initial check

$785K to $1.76M (estimated from fund size)

Estimated from Form D and SEC adviser filing

03 · Who to approach

Named on this fund's Form D

  • Louis Cannon, MD, Founder, Senior Managing Director

04 · Deals

No deals attributed to this fund yet.

05 · Evidence

  • Firm-wideBioStar Capital is a uniquely structured venture capital firm focused on transformative medical technologies.

    we are a uniquely structured venture capital firm focused on transformative medical technologies
    https://www.biostarcapital.com/about

06 · Sources

  1. https://www.biostarcapital.com/about
  2. https://www.sec.gov/Archives/edgar/data/1887386/000188738622000001/

Last verified: Oct 28, 2026